Shares of Park Medi World surged after brokerages Choice Institutional Equities and Emkay Global increased their target prices, citing robust growth prospects and recent hospital expansions in northern India.
Park Medi World was in focus on Wednesday after two brokerages turned more upbeat on the North India-based hospital chain, which has been expanding rapidly since its stock market debut in December 2025. Choice Institutional Equities kept its “Buy” rating and target price of ₹350 a share, while Emkay Global Financial Services also stayed positive and lifted its target to ₹375 from ₹350, according to the company coverage reported by India.com and Market data referenced by Livemint. The revised view from Emkay implies further upside from recent trading levels.
Shares opened lower before recovering through the session, reflecting investor interest after the brokerage updates. The stock was last seen benefiting from a broader reassessment of the group’s growth prospects as analysts pointed to a steady ramp-up in new facilities, stronger earnings momentum and a clear expansion plan across northern India, according to Business Standard and Livemint.
Emkay said Park Medi World’s first quarter in fiscal 2026-27 showed stronger operating performance, with revenue up 19% year on year and EBITDA up 20%. It also pointed to a 156-basis-point improvement in PAT margin and said the gradual increase in utilisation at newly opened hospitals in Panchkula, Rudrapur and Agra, with about 960 beds in total, was supporting confidence in the company’s FY2027 guidance, according to India.com. The brokerage also said the benefits of a better case mix and revised CGHS rates should become more visible later in the year.
The company has been expanding through a cluster-led model, adding hospitals close to existing centres to deepen its regional presence. Business Standard reported that Park Medi World opened a multi-super speciality hospital in Panchkula in April, lifting its combined Tricity capacity to about 850 beds, while the company also announced the acquisition of The Medicity Hospital in Rudrapur for about ₹177 crore, extending it into Uttarakhand. Market reports say the group operates 16 hospitals with 3,960 beds and plans to increase that to 5,460 by March 2028, backed by a capital expenditure programme of about ₹500 crore. Choice has also argued that the business can support strong earnings growth as capacity expands and occupancy improves.
Disclaimer: This article is intended to inform and educate, not to recommend or endorse any financial product, investment or strategy. Please consider your own financial circumstances and seek professional advice where appropriate before making financial decisions.
